75 related articles for article (PubMed ID: 26876283)
1. TopoisomeraseIIβ in HIV-1 transactivation.
Chekuri A; Bhaskar C; Bollimpelli VS; Kondapi AK
Arch Biochem Biophys; 2016 Mar; 593():90-7. PubMed ID: 26876283
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIβ associates with Ku70 and PARP-1 during double strand break repair of DNA in neurons.
Mandraju R; Chekuri A; Bhaskar C; Duning K; Kremerskothen J; Kondapi AK
Arch Biochem Biophys; 2011 Dec; 516(2):128-37. PubMed ID: 22019940
[TBL] [Abstract][Full Text] [Related]
3. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
Kameoka M; Tanaka Y; Ota K; Itaya A; Yoshihara K
Biochem Biophys Res Commun; 1999 Aug; 262(1):285-9. PubMed ID: 10448106
[TBL] [Abstract][Full Text] [Related]
4. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.
Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH
Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364
[TBL] [Abstract][Full Text] [Related]
5. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86.
Trotter KW; King HA; Archer TK
Mol Cell Biol; 2015 Aug; 35(16):2799-817. PubMed ID: 26055322
[TBL] [Abstract][Full Text] [Related]
9. Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling.
Idogawa M; Masutani M; Shitashige M; Honda K; Tokino T; Shinomura Y; Imai K; Hirohashi S; Yamada T
Cancer Res; 2007 Feb; 67(3):911-8. PubMed ID: 17283121
[TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine induces SH-SY5Y cell differentiation toward the neuronal phenotype through activation of the PI3K/Akt/Sp1/TopoIIβ pathway.
Yan YX; Zhao JX; Han S; Zhou NJ; Jia ZQ; Yao SJ; Cao CL; Wang YL; Xu YN; Zhao J; Yan YL; Cui HX
Eur J Cell Biol; 2015 Dec; 94(12):626-41. PubMed ID: 26518113
[TBL] [Abstract][Full Text] [Related]
11. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
13. BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation.
Khan N; Lakpa KL; Halcrow PW; Afghah Z; Miller NM; Geiger JD; Chen X
Sci Rep; 2019 Aug; 9(1):12285. PubMed ID: 31439883
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
15. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.
Chono H; Matsumoto K; Tsuda H; Saito N; Lee K; Kim S; Shibata H; Ageyama N; Terao K; Yasutomi Y; Mineno J; Kim S; Inouye M; Kato I
Hum Gene Ther; 2011 Jan; 22(1):35-43. PubMed ID: 20649483
[TBL] [Abstract][Full Text] [Related]
17. Promoter cleavage: a topoIIbeta and PARP-1 collaboration.
Lis JT; Kraus WL
Cell; 2006 Jun; 125(7):1225-7. PubMed ID: 16814707
[TBL] [Abstract][Full Text] [Related]
18. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
20. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
